Balance Sheet Data
Inovio Pharmaceuticals, Inc. (INO)
$0.3942
+0.02 (+4.20%)
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
| Total Cash | 81.23 | 89.53 | 411.64 | 401.31 | 253 | 1,350.79 | 2,687.77 | 5,348.04 | 10,641.38 | 21,173.91 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Cash (%) | ||||||||||
| Account Receivables | 4.05 | 2.03 | 19.06 | 8.03 | 11.74 | 36.22 | 72.07 | 143.40 | 285.34 | 567.76 |
| Account Receivables (%) | ||||||||||
| Inventories | - | - | - | - | - | - | - | - | - | - |
| Inventories (%) | ||||||||||
| Accounts Payable | 11.02 | 7.65 | 1.47 | 24.76 | 80.91 | 99.06 | 197.11 | 392.19 | 780.38 | 1,552.77 |
| Accounts Payable (%) | ||||||||||
| Capital Expenditure | -2.09 | -0.99 | -1.52 | -1.23 | -0.97 | -5.32 | -10.58 | -21.05 | -41.89 | -83.34 |
| Capital Expenditure (%) |
To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows)
and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.